BCRX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Biocryst Pharmaceuticals Inc (BCRX).


$1.56B Market Cap.

As of 02/26/2025 5:00 PM ET (MRY) • Disclaimer

BCRX Market Cap. (MRY)


BCRX Shares Outstanding (MRY)


BCRX Assets (MRY)


Total Assets

$490.42M

Total Liabilities

$966.35M

Total Investments

$236.46M

BCRX Income (MRY)


Revenue

$450.71M

Net Income

-$88.88M

Operating Expense

$440.77M

BCRX Cash Flow (MRY)


CF Operations

-$52.02M

CF Investing

$52.59M

CF Financing

-$5.76M

BCRX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

BCRX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$490,420,000 (-5.13%)

$516,960,000 (-6.01%)

$550,000,000 (-6.49%)

$588,151,000 (75.72%)

Assets Current

$421,968,000 (-14.92%)

$495,966,000 (-3.98%)

$516,500,000 (-8.77%)

$566,136,000 (74.84%)

Assets Non-Current

$68,452,000 (226.06%)

$20,994,000 (-37.33%)

$33,500,000 (52.17%)

$22,015,000 (101.69%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$475,934,000 (-4.48%)

-$455,528,000 (-54.63%)

-$294,597,000 (-175.36%)

-$106,986,000 (-455.43%)

Property Plant & Equipment Net

$19,785,000 (150.13%)

$7,910,000 (-8.20%)

$8,617,000 (-1.11%)

$8,714,000 (22.51%)

Cash & Equivalents

$104,923,000 (-6.69%)

$112,447,000 (-63.28%)

$306,239,000 (-39.69%)

$507,734,000 (85.07%)

Accumulated Other Comprehensive Income

$921,000 (-31.11%)

$1,337,000 (5042.31%)

$26,000 (-85.31%)

$177,000 (5800.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$1,224,000 (-13.86%)

$1,421,000 (847.33%)

Total Investments

$236,460,000 (-15.05%)

$278,344,000 (102.26%)

$137,620,000 (1270.58%)

$10,041,000 (-64.44%)

Investments Current

$216,137,000 (-22.35%)

$278,344,000 (132.84%)

$119,543,000 (3621.76%)

$3,212,000 (-88.63%)

Investments Non-Current

$20,323,000 (0%)

$0 (0%)

$18,077,000 (164.71%)

$6,829,000 (0%)

Inventory

$31,274,000 (9.03%)

$28,683,000 (4.18%)

$27,533,000 (74.36%)

$15,791,000 (124.34%)

Trade & Non-Trade Receivables

$79,069,000 (38.84%)

$56,950,000 (12.55%)

$50,599,000 (72.03%)

$29,413,000 (240.19%)

Trade & Non-Trade Payables

$11,644,000 (-44.27%)

$20,893,000 (45.53%)

$14,356,000 (-48.37%)

$27,808,000 (48.60%)

Accumulated Retained Earnings (Deficit)

-$1,770,040,000 (-5.29%)

-$1,681,159,000 (-15.57%)

-$1,454,620,000 (-20.47%)

-$1,207,504,000 (-17.98%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$841,418,000 (-0.86%)

$848,713,000 (14.47%)

$741,452,000 (24.98%)

$593,238,000 (112.25%)

Debt Current

$35,448,000 (35.23%)

$26,213,000 (1006.50%)

$2,369,000 (30.24%)

$1,819,000 (-94.17%)

Debt Non-Current

$805,970,000 (-2.01%)

$822,500,000 (11.29%)

$739,083,000 (24.97%)

$591,419,000 (138.17%)

Total Liabilities

$966,354,000 (-0.63%)

$972,488,000 (15.14%)

$844,597,000 (21.50%)

$695,137,000 (96.38%)

Liabilities Current

$160,384,000 (6.93%)

$149,988,000 (42.15%)

$105,514,000 (1.73%)

$103,718,000 (-1.83%)

Liabilities Non-Current

$805,970,000 (-2.01%)

$822,500,000 (11.29%)

$739,083,000 (24.97%)

$591,419,000 (138.17%)

BCRX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$450,712,000 (36.00%)

$331,412,000 (22.37%)

$270,827,000 (72.31%)

$157,170,000 (782.38%)

Cost of Revenue

$12,485,000 (167.86%)

$4,661,000 (-29.31%)

$6,594,000 (-9.22%)

$7,264,000 (333.41%)

Selling General & Administrative Expense

$266,132,000 (24.42%)

$213,894,000 (34.21%)

$159,371,000 (34.13%)

$118,818,000 (74.91%)

Research & Development Expense

$174,638,000 (-19.36%)

$216,566,000 (-14.50%)

$253,297,000 (21.31%)

$208,808,000 (69.81%)

Operating Expenses

$440,770,000 (2.40%)

$430,460,000 (4.31%)

$412,668,000 (25.96%)

$327,626,000 (71.63%)

Interest Expense

$98,516,000 (-8.98%)

$108,239,000 (9.23%)

$99,092,000 (67.12%)

$59,294,000 (308.90%)

Income Tax Expense

$1,927,000 (521.61%)

$310,000 (-88.66%)

$2,733,000 (21.30%)

$2,253,000 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$88,881,000 (60.77%)

-$226,539,000 (8.33%)

-$247,116,000 (-34.26%)

-$184,062,000 (-0.68%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$88,881,000 (60.77%)

-$226,539,000 (8.33%)

-$247,116,000 (-34.26%)

-$184,062,000 (-0.68%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$88,881,000 (60.77%)

-$226,539,000 (8.33%)

-$247,116,000 (-34.26%)

-$184,062,000 (-0.68%)

Weighted Average Shares

$206,696,000 (7.54%)

$192,198,000 (3.38%)

$185,908,000 (3.79%)

$179,117,000 (7.08%)

Weighted Average Shares Diluted

$206,696,000 (7.54%)

$192,198,000 (3.38%)

$185,908,000 (3.79%)

$179,117,000 (7.08%)

Earning Before Interest & Taxes (EBIT)

$11,562,000 (109.80%)

-$117,990,000 (18.79%)

-$145,291,000 (-18.59%)

-$122,515,000 (27.21%)

Gross Profit

$438,227,000 (34.12%)

$326,751,000 (23.66%)

$264,233,000 (76.27%)

$149,906,000 (829.02%)

Operating Income

-$2,543,000 (97.55%)

-$103,709,000 (30.13%)

-$148,435,000 (16.48%)

-$177,720,000 (-1.70%)

BCRX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$52,593,000 (140.00%)

-$131,498,000 (-2.54%)

-$128,238,000 (-911.43%)

$15,804,000 (330.51%)

Net Cash Flow from Financing

-$5,761,000 (-117.73%)

$32,485,000 (-63.10%)

$88,027,000 (-75.53%)

$359,668,000 (19.65%)

Net Cash Flow from Operations

-$52,020,000 (45.32%)

-$95,141,000 (41.22%)

-$161,850,000 (-13.85%)

-$142,157,000 (-5.22%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$6,124,000 (96.84%)

-$193,792,000 (3.82%)

-$201,495,000 (-186.34%)

$233,386,000 (47.13%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$53,717,000 (141.53%)

-$129,330,000 (-1.93%)

-$126,887,000 (-797.60%)

$18,189,000 (386.80%)

Capital Expenditure

-$1,124,000 (48.15%)

-$2,168,000 (-60.47%)

-$1,351,000 (43.35%)

-$2,385,000 (-364.01%)

Issuance (Repayment) of Debt Securities

-$1,704,000 (-106.56%)

$25,975,000 (-64.45%)

$73,072,000 (-75.13%)

$293,874,000 (54.63%)

Issuance (Purchase) of Equity Shares

$3,444,000 (-60.33%)

$8,682,000 (-41.95%)

$14,955,000 (-77.27%)

$65,794,000 (-31.27%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$936,000 (-358.56%)

$362,000 (-36.04%)

$566,000 (697.18%)

$71,000 (0%)

Share Based Compensation

$65,413,000 (17.62%)

$55,615,000 (24.42%)

$44,701,000 (29.04%)

$34,640,000 (134.15%)

Depreciation Amortization & Accretion

$1,246,000 (-24.71%)

$1,655,000 (15.17%)

$1,437,000 (84.94%)

$777,000 (3.88%)

BCRX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

97.20% (-1.42%)

98.60% (1.02%)

97.60% (2.31%)

95.40% (5.30%)

Profit Margin

-19.70% (71.20%)

-68.40% (25.00%)

-91.20% (22.12%)

-117.10% (88.59%)

EBITDA Margin

2.80% (107.98%)

-35.10% (33.90%)

-53.10% (31.48%)

-77.50% (91.76%)

Return on Average Equity (ROAE)

18.70% (-67.31%)

57.20% (-47.09%)

108.10% (-36.11%)

169.20% (121.87%)

Return on Average Assets (ROAA)

-18.50% (57.57%)

-43.60% (5.22%)

-46.00% (11.54%)

-52.00% (38.68%)

Return on Sales (ROS)

2.60% (107.30%)

-35.60% (33.58%)

-53.60% (31.28%)

-78.00% (91.75%)

Return on Invested Capital (ROIC)

1.10% (110.19%)

-10.80% (39.33%)

-17.80% (52.91%)

-37.80% (81.57%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-17.49 (-244.52%)

-5.08 (41.20%)

-8.63 (35.81%)

-13.45 (-96.74%)

Price to Sales Ratio (P/S)

3.45 (-0.72%)

3.47 (-55.91%)

7.88 (-50.08%)

15.78 (-77.44%)

Price to Book Ratio (P/B)

-3.27 (-21.54%)

-2.69 (62.93%)

-7.26 (68.81%)

-23.29 (65.89%)

Debt to Equity Ratio (D/E)

-2.03 (4.92%)

-2.13 (25.53%)

-2.87 (55.87%)

-6.5 (64.65%)

Earnings Per Share (EPS)

-0.43 (63.56%)

-1.18 (11.28%)

-1.33 (-29.13%)

-1.03 (5.50%)

Sales Per Share (SPS)

2.18 (26.51%)

1.72 (18.33%)

1.46 (66.13%)

0.88 (727.36%)

Free Cash Flow Per Share (FCFPS)

-0.26 (49.21%)

-0.51 (42.37%)

-0.88 (-8.80%)

-0.81 (0.49%)

Book Value Per Share (BVPS)

-2.3 (2.83%)

-2.37 (-49.53%)

-1.58 (-165.49%)

-0.6 (-419.13%)

Tangible Assets Book Value Per Share (TABVPS)

2.37 (-11.78%)

2.69 (-9.06%)

2.96 (-9.93%)

3.28 (64.12%)

Enterprise Value Over EBIT (EV/EBIT)

199 (1343.75%)

-16 (11.11%)

-18 (14.29%)

-21 (-162.50%)

Enterprise Value Over EBITDA (EV/EBITDA)

179.74 (1189.21%)

-16.5 (9.17%)

-18.17 (14.89%)

-21.35 (-175.71%)

Asset Turnover

0.94 (47.25%)

0.64 (26.14%)

0.51 (13.74%)

0.44 (434.94%)

Current Ratio

2.63 (-20.44%)

3.31 (-32.44%)

4.89 (-10.32%)

5.46 (78.08%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$53,144,000 (45.39%)

-$97,309,000 (40.37%)

-$163,201,000 (-12.91%)

-$144,542,000 (-6.58%)

Enterprise Value (EV)

$2,302,120,934 (19.92%)

$1,919,748,186 (-26.55%)

$2,613,614,626 (0.57%)

$2,598,873,968 (100.30%)

Earnings Before Tax (EBT)

-$86,954,000 (61.56%)

-$226,229,000 (7.43%)

-$244,383,000 (-34.42%)

-$181,809,000 (0.55%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$12,808,000 (111.01%)

-$116,335,000 (19.13%)

-$143,854,000 (-18.17%)

-$121,738,000 (27.35%)

Invested Capital

$1,066,531,000 (-3.33%)

$1,103,238,000 (25.41%)

$879,699,000 (54.35%)

$569,937,000 (143.34%)

Working Capital

$261,584,000 (-24.39%)

$345,978,000 (-15.82%)

$410,986,000 (-11.12%)

$462,418,000 (111.98%)

Tangible Asset Value

$490,420,000 (-5.13%)

$516,960,000 (-6.01%)

$550,000,000 (-6.49%)

$588,151,000 (75.72%)

Market Capitalization

$1,557,636,934 (26.97%)

$1,226,808,186 (-42.68%)

$2,140,145,626 (-14.12%)

$2,492,115,968 (89.45%)

Average Equity

-$474,067,500 (-19.75%)

-$395,878,500 (-73.12%)

-$228,675,750 (-110.23%)

-$108,773,250 (-560.27%)

Average Assets

$480,496,250 (-7.57%)

$519,876,500 (-3.14%)

$536,713,000 (51.65%)

$353,907,250 (64.18%)

Invested Capital Average

$1,094,308,000 (0.21%)

$1,091,976,500 (33.88%)

$815,653,000 (151.72%)

$324,037,250 (294.79%)

Shares

207,132,571 (1.13%)

204,809,380 (9.86%)

186,423,835 (3.61%)

179,936,171 (1.91%)